Holen Sie sich die Stockscreener-App
1.28
7.56%
0.09
Handel nachbörslich:
1.29
0.01
+0.78%
Schlusskurs vom Vortag:
$1.19
Offen:
$1.1964
24-Stunden-Volumen:
25,754
Relative Volume:
0.80
Marktkapitalisierung:
$58.85M
Einnahmen:
$81.76M
Nettoeinkommen (Verlust:
$-23.96M
KGV:
-1.0492
EPS:
-1.22
Netto-Cashflow:
$-7.50M
1W Leistung:
+4.11%
1M Leistung:
+6.44%
6M Leistung:
+0.00%
1J Leistung:
-3.76%
1-Tages-Spanne:
$1.1964
$1.30
1-Wochen-Bereich:
$1.15
$1.30
52-Wochen-Spanne:
$1.08
$2.58
Theratechnologies Inc Stock (THTX) Company Profile
Firmenname
Theratechnologies Inc
Sektor
Branche
Telefon
-
Adresse
-
Theratechnologies Inc Stock (THTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-11-17 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-07-29 | Herabstufung | Canaccord Genuity | Buy → Hold |
Theratechnologies Inc Aktie (THTX) Neueste Nachrichten
Theratechnologies (TSE:TH) Stock Passes Below Fifty Day Moving AverageTime to Sell? - MarketBeat
Short Interest in Theratechnologies Inc. (NASDAQ:THTX) Rises By 226.0% - MarketBeat
Closing Bell: Theratechnologies Down On Monday (TH) - Barchart
THTX upgraded at Research Capital - Cantech Letter
Theratechnologies (TSE:TH) Stock Price Crosses Above 50 Day Moving AverageHere's Why - MarketBeat
Theratechnologies IDWeek Presentations Highlight the Impact of Excess Visceral Abdominal Fat (EVAF) on Cardiovascular Disease (CVD) Risk in People with HIV - GlobeNewswire
Theratechnologies reports use of HIV drug in severe cases - Investing.com
Theratechnologies reports use of HIV drug in severe cases By Investing.com - Investing.com South Africa
Theratechnologies Unveils Study Design and Baseline Characteristics of PROMISE-US Trial of Ibalizumab in Heavily Treatment-Experienced People with HIV and Multidrug Resistance - GlobeNewswire
Theratechnologies Inc. Forecasted to Earn FY2024 Earnings of $0.04 Per Share (NASDAQ:THTX) - Defense World
Cantor Fitzgerald Weighs in on Theratechnologies Inc.'s FY2024 Earnings (NASDAQ:THTX) - MarketBeat
Earnings call: Theratechnologies reports Q3 profit, raises EBITDA guidance - Investing.com
Theratechnologies (NASDAQ:THTX) Releases Quarterly Earnings Results, Beats Expectations By $0.03 EPS - MarketBeat
Theratechnologies Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Theratechnologies (TSE:TH) Stock Passes Above 50 Day Moving AverageWhat's Next? - MarketBeat
Theratechnologies Inc (THTX) Q3 2024 Earnings Call Highlights: Strong Profitability Amid ... - Yahoo Finance
Theratechnologies: Fiscal Q3 Earnings Snapshot - mySA
Theratechnologies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2024 - Marketscreener.com
Theratechnologies Reports Strong Financial Results and Announces Positive Net Income for Third Quarter 2024 - GlobeNewswire
Earnings to Watch: Theratechnologies Inc (TSX:TH) Reports Q3 202 - GuruFocus.com
Theratechnologies to Present Data at IDWeek 2024 - GlobeNewswire
Theratechnologies (TH) Set to Announce Quarterly Earnings on Thursday - MarketBeat
Theratechnologies Inc. (NASDAQ:THTX) Short Interest Update - MarketBeat
Theratechnologies (TSE:TH) Shares Pass Below Two Hundred Day Moving Average of $1.83 - MarketBeat
Theratechnologies (TSE:TH) Stock Price Crosses Below Two Hundred Day Moving Average of $1.83 - Defense World
Theratechnologies to Announce Third Quarter 2024 Financial Results and Provide Business Update - Brantford Expositor
Theratechnologies Braces for Supply Disruption - TipRanks
Thermon Group Holdings, Inc. (NYSE:THR) Shares Purchased by Victory Capital Management Inc. - Defense World
Thryv Holdings director Amer acquires $22,152 in company stock - Investing.com India
Selling Buzz: Tenet Healthcare Corp. [THC] Principal Accounting Officer Ramsey R. Scott sells 11,599 shares of the company – Knox Daily - Knox Daily
Tenet Healthcare stock hits 52-week high at $166.9 amid robust growth - Investing.com
Insider Selling: Gentherm Incorporated (NASDAQ:THRM) CEO Sells 4,402 Shares of Stock - MarketBeat
Hellenic Telecommunications Organization (OTCMKTS:HLTOY) Sets New 52-Week High at $8.50 - MarketBeat
Tenet Healthcare (NYSE:THC) Sets New 52-Week High at $167.29 - MarketBeat
Hercules Capital (HTGC) Ascends But Remains Behind Market: Some Facts to Note - Yahoo Finance
Gentherm CEO sells over $750k in company stock - Investing.com India
TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch
Teralys Capital says it “should” hit $570-million fund-of-funds target by end of yearBetaKit - BetaKit - Canadian Startup News
Ternium: Still Not A Buy As Near-Term Growth Prospects Remain Unfavorable - Seeking Alpha
Theratechnologies Faces Potential Supply Disruption For Its Top Selling Drug, Warns of Revenue Impact Due To Manufacturing Delays - AOL
Terex Faces Headwinds but Long-Term Outlook Remains Promising - GuruFocus.com
Terex price target lowered to $63 from $67 at Baird - TipRanks
TBIO: Riding the Market Waves of Growth and Decline in 2023 - The InvestChronicle
Are Smart Investors Making the Right Decision? Tenet Healthcare Corp. (THC) - SETE News
Terex sees FY24 adjusted EPS between $5.80 and $6.20 - MSN
TEX’s earnings forecast for the current quarter - US Post News
What's Going On With Theratechnologies Stock On Thursday?Theratechnologies (NASDAQ:THTX) - Benzinga
Transmedics Group Inc [TMDX] President & CEO makes an insider purchase of 8,625 shares worth 1.32 million. - Knox Daily
Finanzdaten der Theratechnologies Inc-Aktie (THTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.02%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):